Paper Details

  1. Home
  2. Paper Details

A clinical comparison of triazolam with placebo and with secobarbital in insomniac patients.

Author: AllensG S, OkawaK K

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Triazolam was found to be more effective than placebo and secobarbital in treating insomnia. In double-blind studies, patients reported better sleep onset, duration, and fewer awakenings with triazolam. There were no differences in alertness the next morning, and side effects did not significantly impact function.
Paper Details　
Original Abstract of the Article :
Seventy-six out-patient insomniacs participated in three different two-night, double-blind crossover trials investigating the hypnotic efficacy andsafety of triazolam. Triazolam 0.5 mg was compared to placebo in one trial conducted K Kay Okawa, MD, and triazolam 0.5 mg was compared to secobarbital 1...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/030006057800600413

データ提供：米国国立医学図書館（NLM）

Triazolam: A Sleep Aid Compared to Placebo and Secobarbital

Insomnia, the elusive enemy of sleep, can be a frustrating and debilitating condition. This study investigates the effectiveness of triazolam, a sleep aid, in treating insomnia. It compares the effects of triazolam to those of placebo and secobarbital, another sleep aid, providing valuable insights into the efficacy and safety of triazolam for treating insomnia. This study is a prime example of how research helps us navigate the complex world of sleep disorders.

Triazolam: A Sleep Aid that Delivers

The study finds that triazolam significantly outperformed both placebo and secobarbital in improving sleep quality. Patients treated with triazolam experienced a faster onset of sleep, longer sleep duration, and fewer nocturnal awakenings. This is a valuable finding for individuals struggling with insomnia, as it suggests that triazolam can be an effective option for improving sleep quality.

Finding the Right Sleep Solution: A Personalized Approach

It's important to note that sleep disorders are complex and individual needs vary. This study provides evidence for the effectiveness of triazolam, but it is essential to consult with a qualified healthcare professional to determine the most appropriate sleep aid for your specific needs.

Dr.Camel's Conclusion

This study provides evidence for the effectiveness of triazolam as a sleep aid. Triazolam significantly outperformed placebo and secobarbital in improving sleep quality. However, it's essential to consult with a healthcare professional to determine the most appropriate treatment for your specific needs.

Date :
  1. Date Completed 1978-11-18
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

28990

DOI: Digital Object Identifier

10.1177/030006057800600413

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.